Isoniazid-Induced Peripheral Neuropathy in Tuberculosis Treatment
Isoniazid (INH) is the most likely cause of the tingling numbness at the fingertips in this patient who has been on anti-TB treatment for three months. 1
Mechanism and Clinical Presentation
Peripheral neuropathy is the most common neurotoxic effect of isoniazid. This adverse effect is:
Dose-related and occurs most frequently in:
- Malnourished patients
- Those predisposed to neuritis (e.g., alcoholics, diabetics)
- "Slow acetylators" of the drug 2
Typically presents as:
- Paresthesias (tingling, numbness) of hands and feet
- Usually begins distally and can progress proximally if untreated
- Sensory symptoms often precede motor involvement 3
Risk Factors
Several factors increase the risk of developing isoniazid-induced peripheral neuropathy:
- Malnutrition
- Diabetes mellitus
- HIV infection
- Alcoholism
- Chronic renal failure
- Pregnancy and lactation
- Advanced age
- Slow acetylator status 1, 4
The patient in this case was taking vitamin supplements, which suggests potential recognition of nutritional concerns, but these may have been insufficient to prevent neuropathy.
Prevention and Management
Preventive measures:
Management of established neuropathy:
Differential Diagnosis
While isoniazid is the most likely culprit, other considerations include:
- Ethambutol: Primarily causes optic neuritis rather than peripheral neuropathy 1
- Pyrazinamide: More commonly causes arthralgia, hepatitis, and rash rather than neuropathy 1
- Rifampicin: Rarely causes peripheral neuropathy; more commonly causes hepatotoxicity, gastrointestinal upset, and "flu-like" syndrome 1
Common Pitfalls to Avoid
- Failing to provide prophylactic pyridoxine to high-risk patients
- Mistaking symptoms for other causes of neuropathy (HIV-related, diabetes, etc.)
- Discontinuing isoniazid prematurely when dose adjustment and pyridoxine supplementation may be sufficient
- Inadequate pyridoxine dosing - therapeutic doses (100-250 mg) are much higher than preventive doses (10-50 mg)
- Overlooking acetylator status - slow acetylators may need dose reduction of isoniazid 4
In conclusion, the clinical presentation of tingling numbness at the fingertips after three months of anti-TB treatment is highly characteristic of isoniazid-induced peripheral neuropathy, which is the most common neurotoxic effect of this medication.